The intricate relationship between diet, metabolic disorders, and cancer progression has garnered significant attention in recent years. Excessive calorie intake is known to trigger the production of ...

Viking Therapeutics has announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.

Novo Nordisk (NVO) stock gains as its weight loss drug succeeds in Phase 3 trial for the liver disease, MASH hurting Eli ...

Big name companies continue to be the focus of interest for investors keen to lift exposure to secular trends like artificial intelligence and anti-obesity drugs. The absence of near-term competition ...

I was scared. “But finally he told me that it’s not only that you’re going to be losing weight, but you’ll also lower your risk of obesity-related diseases.” The mother from Île-Perrot ...

Structure Therapeutics Inc. (NASDAQ:GPCR) was able to report positive results from its phase 2a study using its GLP-1R agonist GSBR-1290 for the treatment of patients with obesity in June 2024.

Overweight and obesity both describe conditions of excessive body fat that presents a risk to health. 2 Excessive fat deposits increase our risk of type 2 diabetes, heart disease, certain cancers, and ...

According to the CDC, as of August 2023, 40.3 percent of U.S. adults—some 100 million people—met the clinical definition for obesity. But this same estimate, which is based on National Health ...

List of countries by obesity rate: Overweight and obesity, resulting from excessive fat accumulation, have become significant health concerns today, with global adult obesity having more than doubled ...

New data released by the Centers for Disease Control and Prevention (CDC) has provided insight into the prevalence of obesity across the United States. The figures, initially from the 2023 Adult ...

Obesity is a multifactorial, chronic, relapsing, non-communicable disease marked by an abnormal and/or excessive accumulation of body fat that presents a risk to health. It is well established that ...